Cholesterol Pill Wins FDA Approval After Cutting LDL Nearly 60%

The FDA approved a new cholesterol pill that cut LDL, the so-called bad cholesterol, by nearly 60% in trials. The oral drug offers a convenient alternative to injectable therapies and could reach millions at risk of heart disease. Its approval marks a potentially significant advance in preventing the leading cause of death worldwide.